This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Taro Pharmaceutical Industries Gestione
Gestione criteri di controllo 2/4
We currently do not have sufficient information about the CEO.
Informazioni chiave
Uday Baldota
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | 6.8yrs |
| Proprietà del CEO | n/a |
| Durata media del management | 8.8yrs |
| Durata media del Consiglio di amministrazione | 7.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Taro Pharmaceutical Industries Ltd. Is An Overlooked Opportunity
Dec 12Taro Pharmaceutical: Sun Pharma Deal Uncertain, No Discernible Value Beyond NAV (Rating Downgrade)
Aug 16Taro Pharmaceutical: Potential Value In Sun Pharma Offer
Jun 02Taro Pharmaceutical: Stagnating Growth At 1.6% Trailing Earnings Yield, Rate Hold
Feb 24Taro Pharmaceutical GAAP EPS of $0.19 misses by $0.68, revenue of $139.2M misses by $23.92M
Jan 24Taro Pharmaceutical Non-GAAP EPS of $0.66 misses by $0.18, revenue of $130.5M misses by $30.52M
Oct 28Taro Pharmaceutical hits 52-week low; down 28% YTD
Aug 15Taro Pharmaceutical Non-GAAP EPS of $1.09 beats by $0.24, revenue of $156.7M beats by $6.8M
Jul 27Taro Pharmaceutical: 10%+ Projected Earnings Yield Is A Strong Calling Card
Jul 14We Think Taro Pharmaceutical Industries' (NYSE:TARO) Healthy Earnings Might Be Conservative
Aug 03
A Look At Taro Pharmaceutical Industries' (NYSE:TARO) Share Price Returns
Jan 26
AMMINISTRATORE DELEGATO
Uday Baldota (54 yo)
6.8yrs
Mandato
Mr. Uday V. Baldota has been Director at Association for Accessible Medicines. He has been the Chief Executive Officer of Taro Pharmaceutical Industries Ltd. since August 28, 2017 and served as its Co-Chie...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 6.8yrs | Nessun dato | Nessun dato | |
| VP, CFO & Chief Accounting Officer | 2.5yrs | Nessun dato | Nessun dato | |
| VP & Head of Operations | 9.5yrs | Nessun dato | Nessun dato | |
| VP and Head of R&D | 12.7yrs | Nessun dato | Nessun dato | |
| Vice President of Technical Services | 14.4yrs | Nessun dato | Nessun dato | |
| Vice President of Scientific and Technical Compliance Manager | no data | Nessun dato | Nessun dato | |
| VP, General Counsel & Secretary | 4.2yrs | Nessun dato | Nessun dato | |
| Vice President of Sales & Marketing | 11.3yrs | US$616.14k | Nessun dato | |
| VP & Head of Human Resource | no data | Nessun dato | Nessun dato | |
| Head of Procurement | 12.5yrs | Nessun dato | Nessun dato | |
| VP & Head of Information Technology | 8yrs | Nessun dato | Nessun dato | |
| VP & Head of U.S. Generics Rx | 5.2yrs | Nessun dato | Nessun dato |
8.8yrs
Durata media
58yo
Età media
Gestione esperta: TARO's management team is seasoned and experienced (8.8 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 7.5yrs | Nessun dato | Nessun dato | |
| Chairman of the Board | 10.9yrs | US$1.00m | Nessun dato | |
| Independent Director | 4.3yrs | Nessun dato | Nessun dato | |
| Director | 13.8yrs | US$500.00k | Nessun dato | |
| Director | 13.1yrs | Nessun dato | Nessun dato | |
| Independent Director | 7.5yrs | Nessun dato | Nessun dato | |
| Vice Chairman | 7.5yrs | Nessun dato | Nessun dato | |
| Independent Director | less than a year | Nessun dato | Nessun dato |
7.5yrs
Durata media
68yo
Età media
Consiglio di amministrazione esperto: TARO's board of directors are considered experienced (7.5 years average tenure).